TSX:CURAPharmaceuticals
Curaleaf Holdings (TSX:CURA) Is Down 8.0% After Mixed 2025 Results And Costly Debt Refinancing - What's Changed
Curaleaf Holdings, Inc. reported past fourth-quarter 2025 revenue of US$333.07 million versus US$327.88 million a year earlier, with quarterly net loss narrowing to US$59.82 million from US$77.56 million, while full-year 2025 revenue declined to US$1.27 billion from US$1.33 billion and net loss increased to US$231.07 million from US$215.42 million.
Alongside these mixed results, Curaleaf expanded its U.S. retail footprint to 162 locations and refinanced US$475 million of 2026 senior secured...